2022
DOI: 10.1016/j.cmet.2022.08.002
|View full text |Cite
|
Sign up to set email alerts
|

Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
85
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 146 publications
(108 citation statements)
references
References 44 publications
0
85
0
Order By: Relevance
“…The first step of glycolysis is catalyzed by hexokinase (HK), which converts glucose to glucose-6-phosphate (G-6-P). Recent studies have shown that HK2 can promote tumour immune evasion by phosphorylating IκBα, leading to the degradation of IκBα, activation of the NF-κB signalling pathway, and elevated PD-L1 expression levels [ 26 ]. We showed that CSFV infection inhibits the rate of extracellular acidification and reduces the overall cellular glycolysis level.…”
Section: Resultsmentioning
confidence: 99%
“…The first step of glycolysis is catalyzed by hexokinase (HK), which converts glucose to glucose-6-phosphate (G-6-P). Recent studies have shown that HK2 can promote tumour immune evasion by phosphorylating IκBα, leading to the degradation of IκBα, activation of the NF-κB signalling pathway, and elevated PD-L1 expression levels [ 26 ]. We showed that CSFV infection inhibits the rate of extracellular acidification and reduces the overall cellular glycolysis level.…”
Section: Resultsmentioning
confidence: 99%
“…Recent studies demonstrated that increased lactic acid in the TME could suppress anticancer immune cells by disturbing their intracellular pH ( Frauwirth et al, 2002 ; Gottfried et al, 2006 ) and impair T cell proliferation and cytokine production ( Brand et al, 2016 ; Fischer et al, 2007 ). Furthermore, Guo et al (2022) revealed that tumor immune evasion can be directly regulated by availability of glucose in the TME. When cancer glycolytic activity competes with immune cells for glucose uptake ( Husain et al, 2013a ; Husain, Seth & Sukhatme, 2013b ), cancer cells could effectively achieve immune evasion.…”
Section: Discussionmentioning
confidence: 99%
“…It converts glucose to glucose-6-phosphate (G-6-P). HK2 is an isoform of HK, and in human glioblastoma cells, elevated glucose levels induce the mitochondrial separation of HK2, which then phosphorylates IκBα, and causes its destruction, thereby transcriptionally enhancing PD-L1, which promotes tumor cell immune evasion and brain tumor development ( Guo et al, 2022 ). It is reported that HK2 deficiency significantly inhibits glycolysis and tumor cell growth in HCC ( Wu et al, 2019 ), while HK2 activity suppression promotes cell death in glioblastoma ( Uludağ et al, 2022 ).…”
Section: Glycolysis-targeted Cancer Therapymentioning
confidence: 99%